BioXcel Therapeutics to Present at the 20th Annual HC Wainwright Global Investment Conference
August 28 2018 - 8:00AM
BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI), a clinical stage
biopharmaceutical development company utilizing novel artificial
intelligence approaches to identify the next wave of medicines
across neuroscience and immuno-oncology, today announced that Dr.
Vimal Mehta, Founder and Chief Executive Officer of BTI, will
present at the 20th Annual Global Investment Conference. The
conference is being held on September 4-6, 2018 in New York City.
Details of the
Conference: |
|
Event: |
20th Annual HC
Wainwright Global Investment Conference |
Date: |
September 5, 2018 |
Time: |
10:50 - 11:15 AM
ET |
A live webcast of the presentation will be accessible through
the Investors section of the Company's website at
www.bioxceltherapeutics.com. Following the conference, the webcast
will be archived on the BioXcel Therapeutics website for 30
days.
In addition to his presentation, Dr. Mehta will be hosting
1-on-1 investor meetings at the conference. Investors attending the
conference who are interested in meeting with BTI management should
contact their HC Wainwright representative.
About BioXcel Therapeutics, Inc.:BioXcel
Therapeutics, Inc. is a clinical stage biopharmaceutical company
focused on drug development that utilizes novel artificial
intelligence approaches to identify the next wave of medicines
across neuroscience and immuno-oncology. The Company's drug
re-innovation approach leverages existing approved drugs and/or
clinically validated product candidates together with big data and
proprietary machine learning algorithms to identify new therapeutic
indices. The Company's two most advanced clinical development
programs are BXCL501, a sublingual thin film formulation designed
for acute treatment of agitation resulting from neurological and
psychiatric disorders, and BXCL701, an immuno-oncology agent
designed for treatment of a rare form of prostate cancer and for
treatment of pancreatic cancer. For more information, please visit
www.bioxceltherapeutics.com.
Contact Information:The Ruth GroupLee Roth/
Janhavi Mohite646-536-7012/7026lroth@theruthgroup.com/
jmohite@theruthgroup.com
BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From Apr 2024 to May 2024
BioXcel Therapeutics (NASDAQ:BTAI)
Historical Stock Chart
From May 2023 to May 2024